MedAlliance Announces Enrollment of over 1,660 Patients in Landmark SELUTION DeNovo Study

GENEVA, Sept. 14, 2023 -- (Healthcare Sales & Marketing Network) -- MedAlliance has announced enrollment of over 1,660 patients in its ground-breaking SELUTION DeNovo coronary randomized study. Recruitment is now half way towards a planned 3,326 patients.... Devices, Interventional, Cardiology MedAlliance, SELUTION SLR, drug-eluting balloon
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news